Literature DB >> 8493430

Practical issues in data monitoring of clinical trials: summary of responses to a questionnaire at NIH.

N L Geller1, M Stylianou.   

Abstract

A targeted poll was undertaken to compare and contrast models of data monitoring of randomized clinical trials sponsored by the National Institutes of Health. In an attempt to represent the institutes which conduct clinical trials, twelve individuals were selected and asked to respond to a questionnaire specifically prepared for this workshop. The response rate was 100 per cent. Most of the large trials sponsored by the institutes have independent, formally constituted data monitoring committees. There was one institute which does not have any data monitoring committees. The questionnaire is described in detail and a summary of the results is given.

Mesh:

Year:  1993        PMID: 8493430     DOI: 10.1002/sim.4780120520

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  4 in total

1.  Experiences and challenges in data monitoring for clinical trials within an international tropical disease research network.

Authors:  M Chen-Mok; M J VanRaden; E S Higgs; R Dominik
Journal:  Clin Trials       Date:  2006       Impact factor: 2.486

Review 2.  Sharing interim trial results by the Data Safety Monitoring Board with those responsible for the trial's conduct and progress: a narrative review.

Authors:  Victoria Borg Debono; Lawrence Mbuagbaw; Lehana Thabane
Journal:  Trials       Date:  2017-03-09       Impact factor: 2.279

3.  Survey of professional views on sharing interim results by the Data Safety Monitoring Board (DSMB): what to share, with whom and why.

Authors:  Victoria Borg Debono; Lawrence Mbuagbaw; James Paul; Norman Buckley; Lehana Thabane
Journal:  Trials       Date:  2018-05-21       Impact factor: 2.279

4.  Exploring factors associated with views on sharing of certain interim trial result measures by the data safety monitoring board (DSMB) with non-DSMB members.

Authors:  Victoria Borg Debono; Lawrence Mbuagbaw; James Paul; Norman Buckley; Lehana Thabane
Journal:  Trials       Date:  2018-11-12       Impact factor: 2.279

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.